evStim
Neurological disorders amenable to Deep Brain Stimulation (e.g., Parkinson's Disease)
Pre-clinicalActive
Key Facts
Indication
Neurological disorders amenable to Deep Brain Stimulation (e.g., Parkinson's Disease)
Phase
Pre-clinical
Status
Active
Company
About NeuroBionics
NeuroBionics is a private, pre-revenue biotech firm founded in 2017 and based in Austin, Texas. The company has developed a proprietary platform of microscale, multifunctional bioelectronic fibers designed for seamless integration with neural tissue. Its lead clinical program, evStim, aims to revolutionize deep brain stimulation (DBS) by enabling endovascular delivery, while its IO fiber serves as a research tool for neuroscience. Backed by foundational MIT research and industry leaders, NeuroBionics is positioned at the intersection of medical devices and regenerative medicine.
View full company profile